| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Cancer Genetics and Gynecological Oncology Programs, University of California San Francisco Cancer Center [D. A. E., R. R. R., A. L., J. M. A.], and the Department of Surgery [J. M. A.], University of California, San Francisco, California 94143; and the Biology Department, University of California, Santa Cruz, California 95064 [G. T., F. J. T.]
Regions where one type of epithelium replaces another (metaplasia) have a predilection for cancer formation. Environmental factors are closely linked to metaplastic carcinogenesis. In particular, cervical cancers associated with human papillomavirus (HPV) infection develop primarily at the transformation zone, a region where metaplastic squamous cells are detected in otherwise columnar epithelial-lined endocervical glands. Previously, we reported estrogen-induced multistage vaginal and cervical carcinogenesis in transgenic mice expressing HPV16 oncogenes in basal squamous epithelial cells. In the present study to investigate the threshold neoplastic response to exogenous estrogen, we treated groups of transgenic mice with lower hormone doses. A 5-fold reduction in estrogen dose induced squamous carcinogenesis solely at the cervical transformation zone compared with other reproductive tract sites. Further study delineated stages of transformation zone carcinogenesis, including formation of hyperplastic lower uterine glands and emergence of multiple foci of squamous metaplasia from individual stem-like glandular reserve cells, followed by neoplastic progression of metaplasia to dysplasia and squamous cancer. We propose that a combination of low-dose estrogen and low-level HPV oncogene expression biases transformation zone glandular reserve cells toward squamous rather than columnar epithelial fate decisions. Synergistic activation of proliferation by viral oncoprotein cell cycle dysregulation and estrogen receptor signaling, together with altered paracrine stromal-epithelial interactions, may conspire to support and promote neoplastic progression and cancer formation.
This article has been cited by other articles:
|
|
 |
|
  J. R. Garbow, A. C. Santeford, J. R. Anderson, J. A. Engelbach, and J. M. Arbeit Magnetic Resonance Imaging Defines Cervicovaginal Anatomy, Cancer, and VEGF Trap Antiangiogenic Efficacy in Estrogen-Treated K14-HPV16 Transgenic Mice Cancer Res., October 15, 2009; 69(20): 7945 - 7952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Colegrove, F. M. D. Gulland, D. K. Naydan, and L. J. Lowenstine Tumor Morphology and Immunohistochemical Expression of Estrogen Receptor, Progesterone Receptor, p53, and Ki67 in Urogenital Carcinomas of California Sea Lions (Zalophus californianus) Vet. Pathol., July 1, 2009; 46(4): 642 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pearse, J. Frith, K. J. Randall, and T. Klinowska Urinary Retention and Cystitis Associated with Subcutaneous Estradiol Pellets in Female Nude Mice Toxicol Pathol, February 1, 2009; 37(2): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Chung, K. Wiedmeyer, A. Shai, K. S. Korach, and P. F. Lambert Requirement for Estrogen Receptor {alpha} in a Mouse Model for Human Papillomavirus-Associated Cervical Cancer Cancer Res., December 1, 2008; 68(23): 9928 - 9934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Herfs, P. Hubert, N. Kholod, J. H. Caberg, C. Gilles, G. Berx, P. Savagner, J. Boniver, and P. Delvenne Transforming Growth Factor-{beta}1-Mediated Slug and Snail Transcription Factor Up-Regulation Reduces the Density of Langerhans Cells in Epithelial Metaplasia by Affecting E-Cadherin Expression Am. J. Pathol., May 1, 2008; 172(5): 1391 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shai, H. C. Pitot, and P. F. Lambert p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers Cancer Res., April 15, 2008; 68(8): 2622 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, S. Fan, Q. Meng, Y. Ma, P. Katiyar, R. Schlegel, and E. M. Rosen BRCA1 Interaction with Human Papillomavirus Oncoproteins J. Biol. Chem., September 30, 2005; 280(39): 33165 - 33177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E M Rosen, S Fan, and C Isaacs BRCA1 in hormonal carcinogenesis: basic and clinical research Endocr. Relat. Cancer, September 1, 2005; 12(3): 533 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Daniel, C. Chiu, E. Giraudo, M. Inoue, L. A. Mizzen, N. R. Chu, and D. Hanahan CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer Cancer Res., March 1, 2005; 65(5): 2018 - 2025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Brake and P. F. Lambert Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model PNAS, February 15, 2005; 102(7): 2490 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Middleton, W. Peh, S. Southern, H. Griffin, K. Sotlar, T. Nakahara, A. El-Sherif, L. Morris, R. Seth, M. Hibma, et al. Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers J. Virol., October 1, 2003; 77(19): 10186 - 10201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Riley, S. Duensing, T. Brake, K. Munger, P. F. Lambert, and J. M. Arbeit Dissection of Human Papillomavirus E6 and E7 Function in Transgenic Mouse Models of Cervical Carcinogenesis Cancer Res., August 15, 2003; 63(16): 4862 - 4871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Castellsague and N. Munoz Chapter 3: Cofactors in Human Papillomavirus Carcinogenesis--Role of Parity, Oral Contraceptives, and Tobacco Smoking J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Sherman Chapter 11: Future Directions in Cervical Pathology J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 72 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Daniel, N. Meyer-Morse, E. K. Bergsland, K. Dehne, L. M. Coussens, and D. Hanahan Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells J. Exp. Med., April 21, 2003; 197(8): 1017 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Ince, A. P. Cviko, B. J. Quade, A. Yang, F. D. McKeon, G. L. Mutter, and C. P. Crum p63 Coordinates Anogenital Modeling and Epithelial Cell Differentiation in the Developing Female Urogenital Tract Am. J. Pathol., October 1, 2002; 161(4): 1111 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Qi, D. Chen, K. Liu, and K. J. Auborn n-6 Polyunsaturated Fatty Acids Increase Skin but not Cervical Cancer in Human Papillomavirus 16 Transgenic Mice Cancer Res., January 1, 2002; 62(2): 433 - 436. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
